Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French transfusion diagnostic market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future marketing and technological trends in France; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin,
Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc,
HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers
of transfusion diagnostic products by individual product.
Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.
- Test volume and sales forecasts for over 40 blood typing,
grouping and infectious disease screening tests,
including NAT, by country and market segment:
- Blood Centers
- Commercial/Private Laboratories
Current and Emerging Products
- Analysis of current and emerging blood typing,
grouping and infectious disease screening tests.
- Review of automated and semi-automated
- Assessment of current and emerging
technologies, and their potential applications
for the transfusion diagnostics market.
- Comprehensive lists of companies developing
or marketing new technologies and products, by test.
- New product development opportunities
with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 430 pages and 43 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch.com provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry - Coagulation - ...
November 2016 | $0 | View Details >>
US Critical Care Diagnostics Market in Ancillary Hospital Locations ERs ORs ICUCCUs Test Volume and Sales Segment Forecasts Supplier Shares Competitive Strategies Innovative Technologies Instrumentation Review
This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.
July 2016 | $0 | View Details >>
2016-2020 Denmark Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales ...
May 2016 | $0 | View Details >>
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
December 2013 | $1500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research